1 – 10 of 16
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Development of interleukin-1 receptor antagonist mutants with enhanced antagonistic activity in vitro and improved therapeutic efficacy in collagen-induced arthritis.
(
- Contribution to journal › Article
- 2006
-
Mark
Escherichia coli TolA tolerates multiple amino-acid substitutions as revealed by screening randomized variants for membrane integrity and phage receptor function
(
- Contribution to journal › Article
- 2005
-
Mark
Genome-wide comparison of phage M13-infected vs. uninfected Escherichia coli
(
- Contribution to journal › Article
- 2003
-
Mark
The mechanism of bacterial infection by filamentous phages involves molecular interactions between TolA and phage protein 3 domains
(
- Contribution to journal › Article
-
Mark
Affinity and Epitope Profiling of Mouse Anti-CD40 Monoclonal Antibodies
(
- Contribution to journal › Article
- 2002
-
Mark
Selection of antibodies based on antibody kinetic binding properties.
(
- Contribution to journal › Article
-
Mark
Modulation of the CD40-CD40 ligand interaction using human anti-CD40 single-chain antibody fragments obtained from the n-CoDeR phage display library
(
- Contribution to journal › Article
-
Mark
In vitro molecular evolution of antibody genes mimicking receptor revision
(
- Contribution to journal › Article
-
Mark
Single framework recombinant antibody fragments designed for protein chip applications
(
- Contribution to journal › Article
- 1998
-
Mark
Characterization of bacteriophages by the use of BIAcore(TM) and Origen Analyzer
(
- Contribution to journal › Article